Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mijin Kim

Showing results (221-230 of 299) with videos related to

Pageof 30
Sort By:
Scientific Reports|February 22, 2018
Passively mode-locked interband cascade optical frequency combsMahmood Bagheri, Clifford Frez, Lukasz A Sterczewski, et al.
Optics Letters|April 16, 2019
Mid-infrared dual-comb spectroscopy with interband cascade lasersLukasz A Sterczewski, Jonas Westberg, Mahmood Bagheri, et al.
Endocrine|April 16, 2021
The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in KoreaSo Young Park, Bo Hyun Kim, Mijin Kim, et al.
Thyroid : Official Journal of the American Thyroid Association|January 8, 2020
Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in KoreaEyun Song, Mijin Kim, Eui Young Kim, et al.
Endocrinology and Metabolism (Seoul, Korea)|September 28, 2020
Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter ExperienceMijin Kim, Jee Hee Yoon, Jonghwa Ahn, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 24, 2016
Association of KCNJ2 Genetic Variants with Susceptibility to Thyrotoxic Periodic Paralysis in Patients with Graves' DiseaseSuyeon Park, Tae Yong Kim, Soyoung Sim, et al.
Endocrinology and Metabolism (Seoul, Korea)|April 4, 2024
Prognostic Roles of Inflammatory Biomarkers in Radioiodine-Refractory Thyroid Cancer Treated with LenvatinibChae A Kim, Mijin Kim, Meihua Jin, et al.
Research Square|February 12, 2024
A pan-cancer agent for screening, resection and wound monitoring via NIR and SWIR imagingBenedict Mc Larney, Ali Sonay, Elana Apfelbaum, et al.
Endocrine|May 10, 2025
Preoperative controlling nutritional status score for patients with medullary thyroid cancerMijin Kim, Hee Kyung Kim, Chae A Kim, et al.
Cancer|June 20, 2019
Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinomaMijin Kim, Bo Hyun Kim, Jeong Mi Kim, et al.
Pageof 30

Showing results (221-230 of 299) with videos related to

Sort By:
Pageof 30
Scientific Reports|February 22, 2018
Passively mode-locked interband cascade optical frequency combsMahmood Bagheri, Clifford Frez, Lukasz A Sterczewski, et al.
Optics Letters|April 16, 2019
Mid-infrared dual-comb spectroscopy with interband cascade lasersLukasz A Sterczewski, Jonas Westberg, Mahmood Bagheri, et al.
Endocrine|April 16, 2021
The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in KoreaSo Young Park, Bo Hyun Kim, Mijin Kim, et al.
Thyroid : Official Journal of the American Thyroid Association|January 8, 2020
Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in KoreaEyun Song, Mijin Kim, Eui Young Kim, et al.
Endocrinology and Metabolism (Seoul, Korea)|September 28, 2020
Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter ExperienceMijin Kim, Jee Hee Yoon, Jonghwa Ahn, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 24, 2016
Association of KCNJ2 Genetic Variants with Susceptibility to Thyrotoxic Periodic Paralysis in Patients with Graves' DiseaseSuyeon Park, Tae Yong Kim, Soyoung Sim, et al.
Endocrinology and Metabolism (Seoul, Korea)|April 4, 2024
Prognostic Roles of Inflammatory Biomarkers in Radioiodine-Refractory Thyroid Cancer Treated with LenvatinibChae A Kim, Mijin Kim, Meihua Jin, et al.
Research Square|February 12, 2024
A pan-cancer agent for screening, resection and wound monitoring via NIR and SWIR imagingBenedict Mc Larney, Ali Sonay, Elana Apfelbaum, et al.
Endocrine|May 10, 2025
Preoperative controlling nutritional status score for patients with medullary thyroid cancerMijin Kim, Hee Kyung Kim, Chae A Kim, et al.
Cancer|June 20, 2019
Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinomaMijin Kim, Bo Hyun Kim, Jeong Mi Kim, et al.
Pageof 30